Patients Request Blood from Donors Who Have Not Received mRNA COVID-19 Shots
A growing number of patients are requesting blood transfusions from donors who have not gotten the COVID19 shot, according to a Mar. 28, 2026 report published in the journal Transfusion. In the report, researchers at Vanderbilt Medical Center Medical Center evaluated 15 cases over a period of two years between 2024 and 2025 in which […]
Pfizer/Valneva Aim for FDA Approval of mRNA Shot for Lyme Disease
On Mar. 23, 2026, Pfizer, Inc. of New York City, NY and Valneva SE of Saint-Herblain, France announced that they would seek regulatory approval from the U.S. Food and Drug Administration (FDA) for an experimental mRNA (messenger ribonucleic acid) biologic shot against Lyme disease that they have jointly been developing since 2020. The shot, designated […]
Pfizer, BioNTech End mRNA COVID-19 Biologic Trial Early
After failing to recruit enough eligible volunteers to generate enough data in the U.S. to meet U.S. Food and Drug Administration (FDA) post-marketing evidence requirements, Pfizer, Inc. and BioNTech SE have halted a large clinical trial of their updated mRNA COVID-19 biologic. The study targeted healthy adults 50 to 64 years of age but fell […]
Poland, Romania Resist Brussels Court Order to Pay $2.2 Billion to Pfizer
A court in Belgium has ordered Poland and Romania to proceed with paying €1.9 billion ($2.2 billion) for purchasing mRNA COVID-19 shots from Pfizer, Inc. and BioNTech SE in a case brought by Pfizer three years ago. The lawsuit and court judgement has intensified a broader legal dispute over mRNA COVID shot contracts signed by […]
Tech Company Agrees to $15 Million Settlement in COVID-19 Shot Bias Claim
An unidentified technology company has agreed to pay $15 million to resolve a federal investigation into alleged discrimination tied to COVID-19 shot exemption requests, according to the U.S. Equal Employment Opportunity Commission (EEOC). The matter was investigated by the EEOC’s Phoenix District Office and focused on the company’s handling of employee requests for religious accommodation during […]
National Cancer Institute to Study Ivermectin as Potential Cancer Treatment
The National Cancer Institute (NCI) plans to conduct a study on the use of ivermectin to treat cancer, according to a top official. Ivermectin is an FDA-approved anti-parasitic medication commonly used to treat various infections caused by internal and external parasites, such as parasitic worms and head lice, though the drug rose in popularity—and scrutiny—during […]